CTU

Advertisement
Oct 14 2025CRYPTO

Binance's Big Weekend: What Went Wrong?

This weekend, the crypto world saw some serious drama. Binance, one of the biggest names in the game, had a rough time. Their wallet service went haywire, showing users' balances as zero. This wasn't a glitch in the matrix, but a real issue caused by network congestion. The platform lagged, and user

reading time less than a minute
Oct 11 2025TECHNOLOGY

Big Tech's AI Infrastructure Race: Who's Spending What?

Big tech companies are in a fierce race to build the infrastructure needed to power AI. This race is not just about building data centers. It's also about securing deals with cloud providers and investing in cutting-edge technology. The stakes are high, with estimates suggesting that up to $4 trilli

reading time less than a minute
Oct 10 2025CRIME

Tragedy Strikes Tennessee: Explosion Rocks Explosives Plant

A powerful explosion has shaken a small town in Tennessee, leaving a trail of destruction and uncertainty. The incident took place at a facility that makes explosives for various industries, including the military. Authorities have confirmed that lives were lost, but the exact number remains unclear

reading time less than a minute
Oct 10 2025EDUCATION

How a Local Company Brought Science to Life

A fresh exhibit is coming to the Reading Science Center, all thanks to the hard work of East Penn Manufacturing employees. The new display, named "Energy in a Box, " is set to open on October 18. It's designed to show how battery plates team up to power engines, while also getting visitors to think

reading time less than a minute
Oct 07 2025FINANCE

Nebius Stock Climbs: Here's Why

Nebius Group N. V. stock is seeing a boost today. Why? Microsoft is getting a lot of NVIDIA chips from them. This is part of a big deal between the two companies. The deal is worth up to $19. 4 billion. It's all about AI. Microsoft wants to use Nebius's computing power for its AI projects. This inc

reading time less than a minute
Oct 06 2025HEALTH

Why Your Ivermectin Might Be Risky and What to Do About It

Ivermectin, a drug used to fight parasites, has gained attention for its potential in treating various ailments, including skin conditions and even cancer. It's affordable and widely available, but there's a catch: most of it comes from China. This raises concerns about safety and quality. The FDA

reading time less than a minute
Oct 05 2025POLITICS

Ukraine's Gas Facilities Under Fire: A Strategic Winter Gambit

In a bold move, Russia has intensified its assault on Ukraine's gas infrastructure, marking one of the largest attacks since the conflict began. This isn't just about military strategy; it's a calculated attempt to disrupt Ukraine's winter preparations and test the resolve of its people. The focus

reading time less than a minute
Oct 03 2025POLITICS

Chicago's Subway Projects Hit by Federal Funding Freeze

The federal government has decided to pause $2. 1 billion in funding for Chicago's subway projects. This move is part of a larger political strategy, targeting cities led by Democrats during the ongoing government shutdown. The projects in question are the Red Line Extension and the Red and Purple

reading time less than a minute
Sep 29 2025TECHNOLOGY

Standing Up to AI: A Writer's Fight Against Big Tech

In 2023, a writer discovered that their books had been used without permission to train AI models. This was a huge shock. The writer was one of many whose work was taken and used to make AI tools like chatbots. The companies behind these tools had taken years of hard work and turned it into data for

reading time less than a minute
Sep 24 2025BUSINESS

Tajikistan's Big Bet on Energy and Roads

Tajikistan is getting a lot of help to build things. Most of the money comes from outside the country. Big groups like the World Bank and the Asian Development Bank are giving almost all the cash for 82 projects. These projects are worth about $4. 5 billion. Out of this, $3. 2 billion is given as gi

reading time less than a minute